Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Serum laser Raman spectroscopy; Non-small cell lung cancer (NSCLC);
مقالات ISI سرطان ریه سلول غیر سلولی (NSCLC) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); CI; confidential interval; CT; computed tomography; DECT; dual-energy computed tomography; GSI; gemstone spectral imaging; HU; hounsfield unit; NSCLC; non-small cell lung cancer; OR; odds ratio; RECIST; response evaluation criteria in solid tumors; ROC; r
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Predictive gene assay; Prognostic protein biomarkers; Non-small cell lung cancer (NSCLC); Chemotherapy; Immunotherapy; Precision therapy;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Programmed cell death 1; PD-1; PDCD1; anti-PD-1 antibody; PD-1 inhibitor; nivolumab; pembrolizumab; acute interstitial nephritis (AIN); acute kidney injury (AKI); non-small cell lung cancer (NSCLC); advanced melanoma; ipilimumab; immune checkpoint inhib
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Personalized medicine; EGFR; ALK; Early detection; Video-assisted thoracoscopic surgery (VATS); Stereotactic ablative radiotherapy (SABR); Immunotherapy
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Nab-paclitaxel; Non-small cell lung cancer (NSCLC); Carboplatin; Neuropathy; Squamous cell histology; Elderly;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); CT ventilation; lung avoidance; magnetic resonance imaging (MRI); non-small cell lung cancer (NSCLC); radiation therapy planning; radiation-induced lung injury;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Lung cancer; Non-small cell lung cancer (NSCLC); Lung adenocarcinoma; Epidermal growth factor receptor (EGFR) mutation;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Adenocarcinoma  of the lung; Non-small cell lung cancer (NSCLC); Solid tumors; Squamous cell lung cancer; Tumor lysis syndrome (TLS);
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Linifanib; Biomarker; Predictive value; non-small cell lung cancer (NSCLC); Carcinoembryonic antigen (CEA); Cytokeratin 19 fragments CYFRA 21-1;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Estrogens; 17-Beta-estradiol; 17-Beta-hydroxysteroid dehydrogenase type 1 (HSD17B1); Gender; Clinicopathological features;
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); EGFR; epidermal growth factor receptor; NSCLC; non-small cell lung cancer; TKI; tyrosine kinase inhibitor; WT; wild type; KRAS; Kirsten RNA associated rat sarcoma 2 virus gene; PTEN; phosphatase and tensin homolog; HGF; hepatocyte growth factor; IGF1R; in
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Sec62; 2D-DIGE; Vimentin; Plastin 3; Epithelial-mesenchymal transition (EMT)
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Long non-coding RNAs (lncRNAs); Co-expression network; Gene ontology (GO); Pathway enrichment analysis
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Forkhead box R2 (FOXR2); Non-small cell lung cancer (NSCLC); Proliferation; Invasion;
Thoracic surgical radiographic and CT pathology: radiology in the radical treatment of lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Lobectomy; non-small cell lung cancer (NSCLC); pneumonectomy; radiofrequency ablation (RFA); stereotactic ablative radiotherapy (SABR); surgery;
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Gefitinib resistance; Tetraploidization; p38 mitogen activating protein kinase (MAPK); Losmapimod;
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); NSCLC; non-small cell lung cancer; UK; United Kingdom; EUCAN; European Cancer Observatory; CI; confidence interval; QoL; quality of life; SAS; Statistical Analysis Software; MRI; magnetic resonance imaging; PET; Positron emission tomography; CT; computed
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Lung cancer; Non-small cell lung cancer (NSCLC); Thoracic surgery; Survival; Prognostic score;
Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Carbonic anhydrase IX (CA IX); Neoadjuvant treatment; Prognosis; Overall survival; Disease free survival;
BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); BRAF mutations; Mitogen activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway; Vemurafenib; Dabrafenib; Trametinib;
Phase I trialPhase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV ⩾ 100 cc
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Dose escalation study; Continual reassessment method; Non-small cell lung cancer (NSCLC); Stereotactic body radiotherapy (SBRT);
ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Societ
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); ALK-Testing; Non-small cell lung cancer (NSCLC); Immunohistochemistry (IHC); Fluorescence in-situ hybridisation (FISH);
MYC expression correlates with PD-L1 expression in non-small cell lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Immune checkpoint inhibitors; Myc; Non-small cell lung cancer (NSCLC); PD-L1;
Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); MutT Homolog 1 (MTH1); Non-small cell lung cancer (NSCLC); Oxidative stress; Surgery;
Experimental radiobiologyInhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Ataxia telangiectasia related-3 (ATR); AZD6738; DNA damage response; Non-small cell lung cancer (NSCLC); Fibrosis; Small animal radiotherapy research platform (SARRP);
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Human monoclonal antibody; Non-small cell lung cancer (NSCLC); Ramucirumab; Refractory patients; Vascular endothelial growth factor (VEGF); Docetaxel; Clinical trial; Histology; Angiogenesis; Phase 3 clinical trial;
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Distance; Mortality; Non-small cell lung cancer (NSCLC); Observational study; Surgery; Cancer bronchique non à petite cellules (CBNPC); Chirurgie; Distance; Ãtude observationnelle; Mortalité;
Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Erlotinib hydrochloride (PubChem CID: 176871); Docetaxel (PubChem CID: 148124); OSI-420 (PubChem CID: 18924996); Docetaxel hydroxy-tert-butyl-carbamate (PubChem CID: 15765777); Gefitinib (PubChem CID: 123631); Non-small cell lung cancer (NSCLC); Erlotinib
Original ArticleUpregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Epithelial-mesenchymal transition (EMT); Slug; miR-137; TFAP2C;
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Anaplastic lymphoma kinase (ALK); Non-small cell lung cancer (NSCLC); Ceritinib; Crizotinib-resistant; G1202R;
Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Epidermal growth factor receptor; Non-small cell lung cancer (NSCLC); Platinum-doublet chemotherapy; T790 M mutation; Tyrosine kinase inhibitor;
Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Telemedicine; Non-small cell lung cancer (NSCLC); Clinical trial; Rural health;
Standardized uptake value on 18F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Standardized uptake value (SUV); T790 M; Epidermal growth factor receptor (EGFR)
HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Hematopoietic pre-B cell leukemia transcription factor (PBX)-interacting protein (HPIP); Non-small cell lung cancer (NSCLC); Cell proliferation; Invasion
Functional imaging in lungSelective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Radiotherapy; Non-small cell lung cancer (NSCLC); Endobronchial ultrasound (EBUS); Intensity-modulated radiotherapy (IMRT); Volumetric arc therapy (VMAT); PET-CT based delineation;
MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); hsa-miRNA-187-5p (miR-187-5p); CYP1B1; Non-small cell lung cancer (NSCLC); Proliferation; Apoptosis;
The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Lymph node metastasis; One-step nucleic acid amplification (OSNA); LN status; Histological examination
MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Hsa-miRNA-187-3p (miR-187-3p); BCL6; Non-small cell lung cancer (NSCLC); Proliferation; Apoptosis;
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Lung cancer; Non-small cell lung cancer (NSCLC); Postoperative radiation therapy (PORT); Incompletely resected NSCLC; Microscopic residual disease
Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Vascular endothelial growth factor A (VEGF-A); MiR-497; Bioinformatics analyses; MiRNAs;
MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Hsa-miRNA-1976 (miR-1976); PLCE1; Non-small cell lung cancer (NSCLC); Proliferation; Apoptosis;
Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Long noncoding RNA XIST; KLF2; Non-small cell lung cancer (NSCLC); Proliferation; Tumorigenesis;
Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTVÂ <Â 100Â cc using a continual reassessment method (JCOG0702)
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Phase I study; Continual reassessment method; Non-small cell lung cancer (NSCLC); Stereotactic body radiotherapy; SBRT;
SEMA4B inhibits growth of non-small cell lung cancer in vitro and in vivo
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); SEMA4B; Non-small cell lung cancer (NSCLC); PI3K; FoxO1; P21;
Elevated levels of preoperative circulating CD44+ lymphocytes and neutrophils predict poor survival for non-small cell lung cancer patients
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Peripheral blood; CD44Â + lymphocytes; Neutrophils; Prognosis;
Investigations of 99mTc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); 99mTc-glucarate (99mTc-GLA); SPECT/CT; Non-small cell lung cancer (NSCLC); Fructose; Glucose transporter 5 (GLUT5); Imaging agent
Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK-rearranged non-small cell lung cancer (NSCLC)
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); Non-small cell lung cancer (NSCLC); Anaplastic lymphoma kinase (ALK) gene rearrangement; Immunohistochemistry (IHC); Antibody 1A4/1H7;
A new PET/CT volumetric prognostic index for non-small cell lung cancer
Keywords: سرطان ریه سلول غیر سلولی (NSCLC); 18F-FDG PET/CT; Non-small cell lung cancer (NSCLC); TNM stage; Tumor burden; Metabolic tumor volume (MTV); Prognosis;